Unit
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Effect of an Augmented Reality Ultrasound Trainer App on the Motor Skills Needed for a Kidney Ultrasound: Prospective Trial
Ebner F, De Gregorio A, Schochter F, Bekes I, Janni W, Lato K. Effect of an Augmented Reality Ultrasound Trainer App on the Motor Skills Needed for a Kidney Ultrasound: Prospective Trial. JMIR Serious Games 2019; 7:e12713.
May 1, 2019Effect of an Augmented Reality Ultrasound Trainer App on the Motor Skills Needed for a Kidney Ultrasound: Prospective Trial
May 1, 2019JMIR Serious Games 2019; 7:e12713
Ebner Florian, De Gregorio Amelie, Schochter Fabienne, Bekes Inga, Janni Wolfgang, Lato Krisztian
Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases
de Gregorio N, de Gregorio A, Ebner F, Friedl T, Huober J, Hefty R, Wittau M, Janni W, Widschwendter P. Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases. Arch Gynecol Obstet 2019; 300:161-168.
Apr 22, 2019Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases
Apr 22, 2019Arch Gynecol Obstet 2019; 300:161-168
de Gregorio N, de Gregorio A, Ebner F, Friedl T W P, Huober Jens, Hefty R, Wittau M, Janni W, Widschwendter P
Luminal Metastatic Breast Cancer
Huober J, Bartsch R, Marme F, Pagani O, Thomssen C. Luminal Metastatic Breast Cancer. Breast Care (Basel) 2019; 14:99-101.
Apr 9, 2019Luminal Metastatic Breast Cancer
Apr 9, 2019Breast Care (Basel) 2019; 14:99-101
Huober Jens, Bartsch Rupert, Marme Frederik, Pagani Olivia, Thomssen Christoph
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension
Bringhen S, Ludwig H, Driessen C, Auner H, Caers J, Gramatzki M, Dimopoulos M, Boccadoro M, Einsele H, Sonneveld P, Cavo M, Goldschmidt H, Milan A, D'Agostino M, Ferri C, Wäsch R, Gay F, Larocca A, Offidani M, Zweegman S, Terpos E, Engelhardt M. Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension. J Intern Med 2019; 286:63-74.
Apr 8, 2019Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension
Apr 8, 2019J Intern Med 2019; 286:63-74
Bringhen S, Ludwig H, Driessen Christoph, Auner H W, Caers J, Gramatzki Martin, Dimopoulos M A, Boccadoro M, Einsele H, Sonneveld P, Cavo M, Goldschmidt H, Milan A, D'Agostino M, Ferri C, Wäsch R, Gay F, Larocca A, Offidani M, Zweegman S, Terpos E, Engelhardt M
Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma
Brünnert D, Kraus M, Stühmer T, Kirner S, Heiden R, Goyal P, Driessen C, Bargou R, Chatterjee M. Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma. Biochim Biophys Acta Mol Basis Dis 2019; 1865:1666-1676.
Apr 4, 2019Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma
Apr 4, 2019Biochim Biophys Acta Mol Basis Dis 2019; 1865:1666-1676
Brünnert Daniela, Kraus Marianne, Stühmer Thorsten, Kirner Stefanie, Heiden Robin, Goyal Pankaj, Driessen Christoph, Bargou Ralf C, Chatterjee Manik
Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland
Samaras P, Zander T, Taverna C, Schmidt A, Pabst T, Mey U, Matthes T, Lerch E, Ketterer N, Heim D, Duchosal M, Driessen C, Betticher D, Bargetzi M, Renner C. Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss Med Wkly 2019; 149:w20031.
Apr 3, 2019Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland
Apr 3, 2019Swiss Med Wkly 2019; 149:w20031
Samaras Panagiotis, Zander Thilo, Taverna Christian, Schmidt Adrian, Pabst Thomas, Mey Ulrich, Matthes Thomas, Lerch Erika, Ketterer Nicolas, Heim Dominik, Duchosal Michel A, Driessen Christoph, Betticher Daniel C, Bargetzi Mario, Renner Christoph
Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia
Schittenhelm M, Lopez C, Fend F, Mau-Holzmann U, Illing B, Akmut F, Bajrami Saipi M, Federmann B, Tsintari V, Walter B, Kampa-Schittenhelm K. Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia. EBioMedicine 2019; 42:340-351.
Apr 2, 2019Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia
Apr 2, 2019EBioMedicine 2019; 42:340-351
Schittenhelm Marcus, Lopez Charles Darin, Fend Falko, Mau-Holzmann Ulrike, Illing Barbara, Akmut Figen, Bajrami Saipi Mihada, Federmann Birgit, Tsintari Vasileia, Walter Bianca, Kampa-Schittenhelm Kerstin
Prolonged tumor response associated with sequential immune checkpoint inhibitor combination treatment and regorafenib in a patient with advanced pretreated hepatocellular carcinoma
Jörger M, Gueller U, Bastian S, Driessen C, von Moos R. Prolonged tumor response associated with sequential immune checkpoint inhibitor combination treatment and regorafenib in a patient with advanced pretreated hepatocellular carcinoma. J Gastrointest Oncol 2019; 10:373-378.
Apr 1, 2019Prolonged tumor response associated with sequential immune checkpoint inhibitor combination treatment and regorafenib in a patient with advanced pretreated hepatocellular carcinoma
Apr 1, 2019J Gastrointest Oncol 2019; 10:373-378
Jörger Markus, Gueller Ulrich, Bastian Sara, Driessen Christoph, von Moos Roger
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment
Diem S, Risch M, Recher M, Risch L, Dummer R, Levesque M, Mangana J, Hillmann D, Niederer R, Berner F, Ali O, Bomze D, Fässler M, Flatz L. Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment. J Immunother 2019; 42:89-93.
Apr 1, 2019Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment
Apr 1, 2019J Immunother 2019; 42:89-93
Diem Stefan, Risch Martin, Recher Mike, Risch Lorenz, Dummer Reinhard, Levesque Mitchell P, Mangana Joanna, Hillmann Dorothea, Niederer Rebekka, Berner Fiamma, Ali Omar Hasan, Bomze David, Fässler Mirjam, Flatz Lukas
Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trial
Cámara R, Singer S, Janni W, Rack B, Widschwendter P, Lato K, Fink V, Deniz M, Friedl T, Schwentner L, Bekes I. Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trial. Breast Cancer Res Treat 2019; 175:627-635.
Mar 21, 2019Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trial
Mar 21, 2019Breast Cancer Res Treat 2019; 175:627-635
Cámara Rafael J A, Singer Susanne, Janni Wolfgang, Rack Brigitte, Widschwendter Peter, Lato Krisztian, Fink Visnja, Deniz Miriam, Friedl Thomas W P, Schwentner Lukas, Bekes Inga
Statins - No more cream for cancer
Gillessen Sommer S, Horvath L. Statins - No more cream for cancer. Eur J Cancer 2019; 112:107-108.
Mar 16, 2019Statins - No more cream for cancer
Mar 16, 2019Eur J Cancer 2019; 112:107-108
Gillessen Sommer Silke, Horvath L G
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Dieckmann K, Heinzelbecker J, Heidenreich A, Cremers J, Oing C, Hermanns T, Fankhauser C, Gillessen Sommer S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Ruf C, Loidl W, Haben B, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Belge G. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study. J Clin Oncol 2019; 37:1412-1423.
Mar 15, 2019Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Mar 15, 2019J Clin Oncol 2019; 37:1412-1423
Dieckmann Klaus-Peter, Heinzelbecker Julia, Heidenreich Axel, Cremers Jann Frederik, Oing Christoph, Hermanns Thomas, Fankhauser Christian Daniel, Gillessen Sommer Silke, Reichegger Hermann, Cathomas Richard, Pichler Martin, Hentrich Marcus, Eredics Klaus, Lorch Anja, Wülfing Christian, Peine Sven, Wosniok Werner, Bokemeyer Carsten, Ruf Christian Guido, Loidl Wolfgang, Haben Björn, Radtke Arlo, Geczi Lajos, Matthies Cord, Anheuser Petra, Eckardt Ulrike, Sommer Jörg, Zengerling Friedemann, Trenti Emanuela, Pichler Renate, Belz Hanjo, Zastrow Stefan, Winter Alexander, Melchior Sebastian, Hammel Johannes, Kranz Jennifer, Bolten Marius, Krege Susanne, Belge Gazanfer
Test of the Einstein Equivalence Principle near the Galactic Center Supermassive Black Hole
GRAVITY Collaboration, Rousset G, Rodríguez-Coira G, Rabien S, Pfuhl O, Perrin G, Perraut K, Paumard T, Ott T, Léna P, Le Bouquin J, Lapeyrère V, Scheithauer S, Sternberg A, Yazici S, Wiezorrek E, Wieprecht E, Widmann F, Waisberg I, von Fellenberg S, Vincent F, Tacconi L, Sturm E, Straubmeier C, Straub O, Lacour S, Kervella P, Jocou L, Eisenhauer F, Eckart A, Ebert M, Duvert G, Dexter J, de Zeeuw P, Coudé du Foresto V, Clénet Y, Brandner W, Berger J, Bauböck M, Förster Schreiber N, Garcia P, Jiménez Rosales A, Hubert Z, Horrobin M, Hippler S, Henning T, Haubois X, Habibi M, Gillessen Sommer S, Genzel R, Gendron E, Gao F, Amorim A. Test of the Einstein Equivalence Principle near the Galactic Center Supermassive Black Hole. Phys Rev Lett 2019; 122:101102.
Mar 15, 2019Test of the Einstein Equivalence Principle near the Galactic Center Supermassive Black Hole
Mar 15, 2019Phys Rev Lett 2019; 122:101102
GRAVITY Collaboration, Rousset G, Rodríguez-Coira G, Rabien S, Pfuhl O, Perrin G, Perraut K, Paumard T, Ott T, Léna P, Le Bouquin J-B, Lapeyrère V, Scheithauer S, Sternberg A, Yazici S, Wiezorrek E, Wieprecht E, Widmann F, Waisberg I, von Fellenberg S, Vincent F, Tacconi L J, Sturm E, Straubmeier C, Straub O, Lacour S, Kervella P, Jocou L, Eisenhauer F, Eckart A, Ebert M, Duvert G, Dexter J, de Zeeuw P T, Coudé du Foresto V, Clénet Y, Brandner W, Berger J P, Bauböck M, Förster Schreiber N M, Garcia P, Jiménez Rosales A, Hubert Z, Horrobin M, Hippler S, Henning Th, Haubois X, Habibi M, Gillessen Sommer Silke, Genzel R, Gendron E, Gao F, Amorim A
Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Putora P, Nestle U, Novello S, Brien M, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Troost E, Van Houtte P, Westeel V, Widder J, Mornex F, McDonald F, Le Pechoux C, Glatzer M, De Ruysscher D, Faivre-Finn C, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, de Marinis F, Dziadiuszko R, Felip E, Früh M, Garrido P, Slotman B. Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts. Radiother Oncol 2019; 135:74-77.
Mar 15, 2019Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Mar 15, 2019Radiother Oncol 2019; 135:74-77
Putora Paul Martin, Nestle Ursula, Novello Silvia, Brien Mary O', Paz Ares Luis, Peeters Stephanie, Pöttgen Christoph, Ramella Sara, Reck Martin, Troost Esther G C, Van Houtte Paul, Westeel Virginie, Widder Joachim, Mornex Francoise, McDonald Fiona, Le Pechoux Cecile, Glatzer Markus, De Ruysscher Dirk, Faivre-Finn Corinne, Belderbos Jose, Besse Benjamin, Blackhall Fiona, Califano Raffaele, Cappuzzo Federico, de Marinis Filippo, Dziadiuszko Rafal, Felip Enriqueta, Früh Martin, Garrido Pilar, Slotman Ben J
Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial
Rothé F, Wardley A, Ueno T, Janni W, Huober J, Baselga J, Piccart M, Loi S, Sotiriou C, Dawson S, Chia S, Rosa D, Di Cosimo S, Silva M, Venet D, Campbell C, Bradburry I, Rouas G, de Azambuja E, Maetens M, Fumagalli D, Rodrik-Outmezguine V, Ignatiadis M. Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial. Clin Cancer Res 2019; 25:3581-3588.
Mar 12, 2019Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial
Mar 12, 2019Clin Cancer Res 2019; 25:3581-3588
Rothé Françoise, Wardley Andrew, Ueno Takayuki, Janni Wolfgang, Huober Jens, Baselga José, Piccart Martine, Loi Sherene, Sotiriou Christos, Dawson Sarah-Jane, Chia Stephen, Rosa Daniela, Di Cosimo Serena, Silva Maria Joao, Venet David, Campbell Christine, Bradburry Ian, Rouas Ghizlane, de Azambuja Evandro, Maetens Marion, Fumagalli Debora, Rodrik-Outmezguine Vanessa, Ignatiadis Michail
Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort
Schmid S, Aeppli S, Früh M. Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort. Lung Cancer 2019
Mar 5, 2019Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort
Mar 5, 2019Lung Cancer 2019
Schmid Sabine, Aeppli Stefanie, Früh Martin
Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO Trial
Di Cosimo S, Verderio P, Apolone G, de Braud F, Piccart M, Baselga J, Huober J, Izquierdo M, de la Pena L, de Azambuja E, Hilbers F, Iorio M, Tiberio P, Pizzamiglio S, Appierto V, Daidone M. Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO Trial. Clin Cancer Res 2019; 25:3887-3895.
Feb 27, 2019Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO Trial
Feb 27, 2019Clin Cancer Res 2019; 25:3887-3895
Di Cosimo Serena, Verderio Paolo, Apolone Giovanni, de Braud Filippo G, Piccart Martine, Baselga José, Huober Jens, Izquierdo Miguel, de la Pena Lorena, de Azambuja Evandro, Hilbers Florentine, Iorio Marilena V, Tiberio Paola, Pizzamiglio Sara, Appierto Valentina, Daidone Maria Grazia
Management of cardiovascular risk in patients with multiple myeloma
Plummer C, Driessen C, Szabo Z, Mateos M. Management of cardiovascular risk in patients with multiple myeloma. Blood Cancer J 2019; 9:26.
Feb 26, 2019Management of cardiovascular risk in patients with multiple myeloma
Feb 26, 2019Blood Cancer J 2019; 9:26
Plummer Chris, Driessen Christoph, Szabo Zsolt, Mateos Maria-Victoria
The European Prostate Cancer Centres of Excellence: A Novel Proposal from the European Association of Urology Prostate Cancer Centre Consensus Meeting
Wirth M, Pieters B, Ribal M, Sangar V, Schoots I, Smelov V, Travado L, Valdagni R, Wesselmann S, Wiegel T, Müller S, Mottet N, Fossati N, Albers P, Bangma C, Brausi M, Compérat E, Faithfull S, Gillessen Sommer S, Jereczek-Fossa B, Mastris K, Van Poppel H. The European Prostate Cancer Centres of Excellence: A Novel Proposal from the European Association of Urology Prostate Cancer Centre Consensus Meeting. Eur Urol 2019; 76:179-186.
Feb 22, 2019The European Prostate Cancer Centres of Excellence: A Novel Proposal from the European Association of Urology Prostate Cancer Centre Consensus Meeting
Feb 22, 2019Eur Urol 2019; 76:179-186
Wirth Manfred, Pieters Bradley, Ribal Maria J, Sangar Vijay, Schoots Ivo G, Smelov Vitaly, Travado Luzia, Valdagni Riccardo, Wesselmann Simone, Wiegel Thomas, Müller Stefan C, Mottet Nicolas, Fossati Nicola, Albers Peter, Bangma Chris, Brausi Maurizio, Compérat Eva, Faithfull Sara, Gillessen Sommer Silke, Jereczek-Fossa Barbara Alicja, Mastris Ken, Van Poppel Hendrik
Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98
Kensler K, Brown M, Viale G, Colleoni M, Thürlimann B, Kammler R, Hazra A, Schnitt S, Pyle M, Baker G, Heng Y, Regan M, Tamimi R. Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98. Breast Cancer Res 2019; 21:30.
Feb 22, 2019Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98
Feb 22, 2019Breast Cancer Res 2019; 21:30
Kensler Kevin H, Brown Myles, Viale Giuseppe, Colleoni Marco, Thürlimann Beat, Kammler Roswitha, Hazra Aditi, Schnitt Stuart J, Pyle Michael E, Baker Gabrielle M, Heng Yujing J, Regan Meredith M, Tamimi Rulla M